Consistent with the findings that intestinal AMPK, which mediates NAMPT activation, is impaired in glucose intolerance, HFD-induced obesity, and aging downregulates the major NAD+-generating enzymes, including NAMPT, and reduces intestinal NAD+ levels [31,99,100]. The gene discussed is NAMPT; the disease is Glucose intolerance.